Liang Schweizer On Raising $180 Million To Mobilize the Human Immune System To Combat Diseases

Liang Schweizer has now raised close to $180M for her biotech startup. Including a $75M Series D round. Her venture, HiFiBio has acquired funding from top-tier investors like Grand Mount Capital, IDG Capital, Legend Star, and Maison Capital.